Myeloproliferative Disorders
The MPN Research Foundation is dedicated to advancing research and funding for innovative treatments and potential cures for myeloproliferative neoplasms (MPNs), including essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF). Through a collaborative approach, the foundation emphasizes the importance of integrating patient perspectives into research and drug development.
With a rich history of supporting influential research discoveries, the foundation engages patients, caregivers, clinicians, and the biotech industry to foster impactful advancements in MPN therapies. By investing in medical research, the MPN Research Foundation aims to enhance patient outcomes and quality of life for those affected by these chronic blood cancers.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.


